Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05201014 · ClinicalTrials.gov registry record
Cancer Survivor Cardiomyopathy Detection
A clinical trial of Cancer and Cardiovascular Diseases, sponsored by Mayo Clinic.
- Active
- Registry status
- 112
- Enrollment target
- 1
- Study location
NCT05201014 is a study of Cancer and Cardiovascular Diseases that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 112 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05201014, a study of Cancer and Cardiovascular Diseases, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Echocardiogram
- DIAGNOSTIC_TEST Electrocardiogram
- DIAGNOSTIC_TEST NT-pro-BNP
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2022-03-03 |
| Est. Completion | 2026-09-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05201014
The ClinicalTrials.gov registry entry for NCT05201014 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Echocardiogram is the first listed.
NCT05201014 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05201014 about?
NCT05201014 is a clinical study titled "Cancer Survivor Cardiomyopathy Detection". The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.
What is the current status of trial NCT05201014?
This trial is currently active not recruiting. The enrollment target is 112 participants. The study started on 2022-03-03. Estimated completion is 2026-09-20.
What conditions does trial NCT05201014 study?
This clinical trial studies the following conditions: Cancer, Cardiovascular Diseases.
What interventions are being tested in trial NCT05201014?
The interventions under investigation include: Echocardiogram (DIAGNOSTIC_TEST), Electrocardiogram (DIAGNOSTIC_TEST), NT-pro-BNP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05201014?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05201014 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.